223 related articles for article (PubMed ID: 17443002)
1. Toward a molecular classification of melanoma.
Fecher LA; Cummings SD; Keefe MJ; Alani RM
J Clin Oncol; 2007 Apr; 25(12):1606-20. PubMed ID: 17443002
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy for melanoma: a primer.
Davies MA; Gershenwald JE
Surg Oncol Clin N Am; 2011 Jan; 20(1):165-80. PubMed ID: 21111965
[TBL] [Abstract][Full Text] [Related]
3. Delving into somatic variation in sporadic melanoma.
Walia V; Mu EW; Lin JC; Samuels Y
Pigment Cell Melanoma Res; 2012 Mar; 25(2):155-70. PubMed ID: 22260482
[TBL] [Abstract][Full Text] [Related]
4. Advances in melanoma: epidemiology, diagnosis, and prognosis.
Waseh S; Lee JB
Front Med (Lausanne); 2023; 10():1268479. PubMed ID: 38076247
[TBL] [Abstract][Full Text] [Related]
5. Melanoma: from melanocyte to genetic alterations and clinical options.
Bertolotto C
Scientifica (Cairo); 2013; 2013():635203. PubMed ID: 24416617
[TBL] [Abstract][Full Text] [Related]
6. Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy.
Bradish JR; Richey JD; Post KM; Meehan K; Sen JD; Malek AJ; Katona TM; Warren S; Logan TF; Fecher LA; Cheng L
Mod Pathol; 2015 Apr; 28(4):480-6. PubMed ID: 25376477
[TBL] [Abstract][Full Text] [Related]
7. Genomic Classification of Cutaneous Melanoma.
Cancer Genome Atlas Network
Cell; 2015 Jun; 161(7):1681-96. PubMed ID: 26091043
[TBL] [Abstract][Full Text] [Related]
8. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway.
Elder DE; Bastian BC; Cree IA; Massi D; Scolyer RA
Arch Pathol Lab Med; 2020 Apr; 144(4):500-522. PubMed ID: 32057276
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics of malignant melanoma.
Moran B; Silva R; Perry AS; Gallagher WM
Semin Cancer Biol; 2018 Aug; 51():80-88. PubMed ID: 29074395
[TBL] [Abstract][Full Text] [Related]
10. Cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract][Full Text] [Related]
11. Strategies for early melanoma detection: Approaches to the patient with nevi.
Goodson AG; Grossman D
J Am Acad Dermatol; 2009 May; 60(5):719-35; quiz 736-8. PubMed ID: 19389517
[TBL] [Abstract][Full Text] [Related]
12. Construction and Identification of an NLR-Associated Prognostic Signature Revealing the Heterogeneous Immune Response in Skin Cutaneous Melanoma.
Geng Y; Sun YJ; Song H; Miao QJ; Wang YF; Qi JL; Xu XL; Sun JF
Clin Cosmet Investig Dermatol; 2023; 16():1623-1639. PubMed ID: 37396711
[TBL] [Abstract][Full Text] [Related]
13. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM.
Zhang W; Xie X; Huang Z; Zhong X; Liu Y; Cheong KL; Zhou J; Tang S
Front Immunol; 2022; 13():919145. PubMed ID: 36211371
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
16. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
17. From melanocytes to melanomas.
Shain AH; Bastian BC
Nat Rev Cancer; 2016 Jun; 16(6):345-58. PubMed ID: 27125352
[TBL] [Abstract][Full Text] [Related]
18. Glucaric acids from Leonurus japonicus.
Jiang J; Li Y; Feng Z; Yang Y; Zhang P
Fitoterapia; 2015 Dec; 107():85-89. PubMed ID: 26526024
[TBL] [Abstract][Full Text] [Related]
19. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]